Volume 19, Issue 3, 2023
An Explicative Review on the Progress of Quinazoline Scaffold as Bioactive Agents in the Past Decade
Pp: 211-245
Author(s): Naman Jain, Tanvi Goel, Snehal Thakar, Madhav Jadhav and Deepali Bansode*
DOI: 10.2174/1573406418666220606093202
Published on: 03 October, 2022
Design, Synthesis, and Molecular Docking Study of Novel 3-Cyanopyridine Derivatives for the Anti-Cancer Drug Target Survivin Protein
Pp: 246-262
Author(s): Jia-Hao Lu, Wu-Ji Lai, Li-He Jiang, Fu-Hou Lei, Li-Qun Shen* and Ai-Qun Wu*
DOI: 10.2174/1573406418666220829160820
Published on: 12 October, 2022
Revisiting Purine Nucleoside Cholinesterase Inhibitors - An Experimental Glycon Structure/Activity Relationship Study
Pp: 263-275
Author(s): Vasco Cachatra, Maria Conceição Oliveira, Oscar Lopez, José G. Fernandez-Bolaños and Amélia Pilar Rauter*
DOI: 10.2174/1871520622666220527150712
Published on: 04 October, 2022
Design, Synthesis, and Evaluation of Novel Pyruvate Dehydrogenase Kinase Inhibitors
Pp: 276-296
Author(s): Deniz Arslan, Matthieu Schoumacher, Sébastien Dilly, Benaïssa Elmoualij, Danièle Zorzi, Pascale Quatresooz, Vincent Lambert, Agnès Noël, Bernard Pirotte* and Pascal de Tullio
DOI: 10.2174/1573406418666220819102627
Published on: 03 October, 2022
Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19
Pp: 297-309
Author(s): Lok Yong Hui, Chan Sook Mun, Lai Cong Sing, Harish Rajak, Rohini Karunakaran and Veerasamy Ravichandran*
DOI: 10.2174/1573406418666220616110351
Published on: 03 October, 2022
